Skip to main content

Publications

featured publications

  • Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysis.

    Research and practice in thrombosis and haemostasis

    Authors: Ilja Oomen, Ricardo M Camelo, Suely Meireles Rezende, Jan Voorberg, Maria Elisa Mancuso, Johannes Oldenburg, Manuel Carcao, Davide Matino, David Lillicrap, Kathelijn Fischer, Karin Fijnvandraat, Samantha C Gouw

  • Gene therapy of Hemophilia: Recommendations from the German, Austrian, and Swiss Society for Thrombosis and Haemostasis Research (GTH).

    Hamostaseologie

    Authors: Wolfgang Miesbach, Johannes Oldenburg, Robert Klamroth, Hermann Eichler, Jürgen Koscielny, Susanne Holzhauer, Katharina Holstein, Johanna A Kremer Hovinga, Lorenzo Alberio, Martin Olivieri, Ralf Knöfler, Christoph Male, Andreas Tiede

  • Top publication

    Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ Tregs.

    The Journal of clinical investigation

    Authors: Janine Becker-Gotot, Mirjam Meissner, Vadim Kotov, Blanca Jurado-Mestre, Andrea Maione, Andreas Pannek, Thilo Albert, Chrystel Flores, Frank A Schildberg, Paul A Gleeson, Birgit M Reipert, Johannes Oldenburg, Christian Kurts

  • Ex Vivo Modeling of the PC (Protein C) Pathway Using Endothelial Cells and Plasma: A Personalized Approach.

    Arteriosclerosis, thrombosis, and vascular biology

    Authors: Nadine Schwarz, Jens Müller, Hamideh Yadegari, Hannah L McRae, Sara Reda, Nasim Shahidi Hamedani, Johannes Oldenburg, Bernd Pötzsch, Heiko Rühl

  • Genetic landscape in coagulation factor XIII associated defects - Advances in coagulation and beyond.

    Blood reviews

    Authors: Haroon Javed, Sneha Singh, Samhitha Urs Ramaraje Urs, Johannes Oldenburg, Arijit Biswas

  • Emicizumab dose up-titration in case of suboptimal bleeding control in people with haemophilia A.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Christophe Schmitt, Maria Elisa Mancuso, Tiffany Chang, Maria Podolak-Dawidziak, Claire Petry, Robert Sidonio, Koichiro Yoneyama, Nigel S Key, Markus Niggli, Michaela Lehle, Flora Peyvandi, Johannes Oldenburg

  • Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B.

    The New England journal of medicine

    Authors: Johannes Oldenburg

  • Clinical experience of switching patients with severe hemophilia to rVIII-SingleChain or rIX-FP.

    Current medical research and opinion

    Authors: Johannes Oldenburg, Steven W Pipe, Maria Elisa Mancuso, Robert Klamroth, Abel Hassoun, Martin Olivieri, Georg Goldmann, Gili Kenet, Wolfgang Miesbach, Jolana Schmiedl, Inga Hegemann

  • Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1-3.

    Research and practice in thrombosis and haemostasis

    Authors: Michael U Callaghan, Elina Asikanius, Michaela Lehle, Johannes Oldenburg, Johnny Mahlangu, Marianne Uguen, Sammy Chebon, Rebecca Kruse-Jarres, Víctor Jiménez-Yuste, Midori Shima, Peter Trask, Christine L Kempton, Craig M Kessler, Gallia G Levy, Flora Peyvandi

  • Assay for ADAMTS-13 Activity with Flow Cytometric Readout.

    ACS omega

    Authors: Jens Müller, Nasim Shahidi Hamedani, Hannah L McRae, Heiko Rühl, Johannes Oldenburg, Bernd Pötzsch